Welcome to the CV Technologies HUB on AGORACOM
COLD-fX remains the #1 selling cold and flu remedy in Canada
  • Demo Video
  • Private Messages
  • Edit My Profile
  • View/Edit Portfolio

AGORACOM News Flash

AGORACOM WIRE - MONDAY MAY 28TH, 2012

SONOMAX completes $3 million equity financing

Caisse de dépôt et placement du Québec contributes a significant portion of financing

FOCUS METALS (TSXV:FMS) Changes Its Name to Focus Graphite Inc. Read More   |   *SPONSOR

INTERNATIONAL PBX VENTURES (TSX:PBX) Signs Copaquire Joint Venture Option Agreement - $90M Potential Payment Read More

LOMIKO METALS (TSXV:LMR) Graphite and Zinc Price Outlook is Favourable Through 2013  Read More   |   *SPONSOR

 

 

Message: Q2 out, sales up 36% over last yr

Generic_profile
Rank: [?]
Mail Room
Points: [?]
7
Rating: [?]
Votes: 0
  • Currently 0.0/5 Stars.
Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.

Re: Q2 out,

in response to Re: Q2 out, by robybob
posted on Jun 18, 08 11:08AM

As best as I can understand it CV have quite sensibly re-trenched by concentrating on properly developing their home market.

I for one do not expect any fireworks here in the forseeable future and am hoping to get a decent profit on something else in order to offset my huge loss on these.

Notwithstanding my own sad position it remains a fact that ColdFX remains the #1 seller in the alleviation of flu within Canada.

A somewhat dull situation.



New Message

Please login to post a reply

AGORACOM Quick Tips

Breaking Small-Cap News Delivered to your Smart Phone! Grab our RSS Feed

President's D.D.

New feature: Hub Presidents can add important links here.

Hub Leaders